C07C 311/59
Having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of
Official title: having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
C07C311/59 (Having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of) appears on 21 US grants and 24 published applications in this corpus.
Search patents in C07C- Granted patents
- 21
- Published applications
- 24
- Assignees
- 23
- Inventors
- 73
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 2 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 2 | 3 |
| 2017 | 3 | 3 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 2 | 2 |
| 2024 | 1 | 0 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Probenecid compounds for the treatment of inflammasome-mediated lung disease17 Mar 2026US 12,577,211 B2Bacainn Biotherapeutics, Ltd.
- Sulfonylurea derivative and medical uses thereof9 Dec 2025US 12,492,166 B2Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Cycloheptylamine derivatives as anti-diabetic agents6 Feb 2024US 11,891,348 B2United Arab Emirates University
- Compounds and uses12 Dec 2023US 11,840,543 B2The Provost, Fellows, Foundation Scholars, and the Other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth Near Dublin
- Cycloheptylamine derivatives as anti-diabetic agents1 Aug 2023US 11,713,290 B2United Arab Emirates University
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Probenecid compounds for the treatment of inflammasome-mediated dermatological conditions25 Jun 2026US 2026/0176232 A1Bacainn Biotherapeutics, Ltd.
- Sulfonylurea compound, preparation method therefor, and application thereof8 May 2025US 2025/0145564 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Sulfonamide derivatives and their use as soluble epoxide hydrolase inhibitors13 Feb 2025US 2025/0049736 A1
- Sulfonylurea derivative and medical uses thereof2 Nov 2023US 2023/0348371 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Most cited
By later US patents
- Cycloalkyl inhibitors of potassium channel function24US 7,202,253 B2Bristol-Myers Squibb Company · 2007
- Benzenesulfonyl ureas6US 3,932,503 AHoechst Aktiengesellschaft · 1976
- Thromboxane receptor antagonists6US 9,388,127 B2University College Dublin, National University of Ireland, Dublin · 2016
- Thiazolidine derivatives and their use as salidiuretics5US 4,083,979 AHoechst Aktiengesellschaft · 1978
- N-cyclohexylaminocarbonyl benzensulfonmide derivatives4US 7,319,170 B2Merck & Co., Inc. · 2008